International Circulation:  You mention the VALUE trial. What about the ACCOMPLISH trial， which was a high risk population as well.  How will that influence the guidelines – we have the JNC 8 coming out from the US and perhaps the ESC ESH.  Can you comment on that briefly?

《国际循环》：您提到了VALUE研究，那么对同样针对高危人群的ACCOMPLISH研究您如何看待？这会对指南有何影响—— 美国即将出台JNC 8，另外还可能有ESC/ESH高血压指南？您能否简单评论一下？

Professor Unger:  The ACCOMPLISH trial was a hypertension trial to compare the ACE

上一页  [1]  [2]  [3]  [4]  [5]